Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase III, Randomized, Active-Comparator Controlled Clinical Trial to Evaluate the Efficacy and Safety of Nifedipine 30 mg Extended-Release in Adult Patients Diagnosed With Mild or Moderate Hypertension in Colombia

NCT07448506 is registered in ClinicalTrials.gov with Laboratorios Richmond S.A.C.I.F. as lead sponsor.

NCT NCT07448506
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07448506 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase III, Randomized, Active-Comparator Controlled Clinical Trial to Evaluate the Efficacy and Safety of Nifedipine 30 mg Extended-Release in Adult Patients Diagnosed With Mild or Moderate Hypertension in Colombia
Lead sponsor
Laboratorios Richmond S.A.C.I.F.
Phase
Phase 3
Overall status
Completed
Start date
July 9, 2024
Completion date
August 13, 2025
Enrollment
50 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

high blood pressure (& [essential hypertension])